152 related articles for article (PubMed ID: 38605312)
1. The inhibitory effects of carvacrol, nystatin, and their combination on oral candidiasis isolates.
Balef SSH; Hosseini SS; Asgari N; Sohrabi A; Mortazavi N
BMC Res Notes; 2024 Apr; 17(1):104. PubMed ID: 38605312
[TBL] [Abstract][Full Text] [Related]
2. Anti-biofilm properties of eucalyptol in combination with antifungals against Candida albicans isolates in patients with hematological malignancy.
Keymaram M; Falahati M; Farahyar S; Lotfali E; Abolghasemi S; Mahmoudi S; Sadeghi F; Khalandi H; Ghasemi R; Shamsaei S; Raiesi O
Arch Microbiol; 2022 May; 204(6):295. PubMed ID: 35508567
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
4. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
5. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study.
Özdal Zincir Ö; Özdal U; Ünlü Ö; Demirci M; Katiboğlu AB; Egil E; Altan Şallı G
Odontology; 2022 Apr; 110(2):330-337. PubMed ID: 34657217
[TBL] [Abstract][Full Text] [Related]
7. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
da Silva RA; Ishikiriama BLC; Ribeiro Lopes MM; de Castro RD; Garcia CR; Porto VC; Santos CF; Neppelenbroek KH; Lara VS
Oral Dis; 2020 Nov; 26(8):1810-1819. PubMed ID: 32583467
[TBL] [Abstract][Full Text] [Related]
9. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre-Urizar JM; Quindós G; Eraso E
Biomed Pharmacother; 2021 Nov; 143():112218. PubMed ID: 34649348
[TBL] [Abstract][Full Text] [Related]
11. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of Candida albicans from patients with chronic oral candidiasis.
Holbrook WP; Kippax R
Postgrad Med J; 1979 Sep; 55(647):692-4. PubMed ID: 392486
[TBL] [Abstract][Full Text] [Related]
13. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis.
Dias IJ; Trajano ERIS; Castro RD; Ferreira GLS; Medeiros HCM; Gomes DQC
Braz J Biol; 2018 May; 78(2):368-374. PubMed ID: 28977047
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effect of Standardized Extract and Fractions of
Jahantiq AS; Ayatollahi Mousavi SA; Mohamadi N; Sharififar F
Curr Drug Discov Technol; 2022; 19(5):e120522204695. PubMed ID: 35549875
[TBL] [Abstract][Full Text] [Related]
17. [Phenomenon of increased resistance of yeast-like fungi to nystatin].
Nierebińska E; Gwieździński Z; Urbanowski S; Pracz M
Wiad Lek; 1992 Jun; 45(11-12):427-9. PubMed ID: 1441524
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility to nystatin of oral Candida isolates and its correlation with the response to treatment].
Santa Anna LM; Díaz Suárez LA; Illnait Zaragozí MT; Perurena Lancha MR; Cantelar de Francisco N; Fernández Andreu CM; Martínez Machín G
Rev Cubana Med Trop; 2010; 62(3):237-44. PubMed ID: 23437555
[TBL] [Abstract][Full Text] [Related]
19. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
20. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]